nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—Breast feeding—Octreotide—thymus cancer	0.0877	0.0902	CcSEcCtD
Norethindrone—Abdominal bloating—Octreotide—thymus cancer	0.0644	0.0662	CcSEcCtD
Norethindrone—Pregnancy—Octreotide—thymus cancer	0.054	0.0555	CcSEcCtD
Norethindrone—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.0521	0.0536	CcSEcCtD
Norethindrone—Abdominal cramps—Octreotide—thymus cancer	0.0454	0.0467	CcSEcCtD
Norethindrone—Metrorrhagia—Octreotide—thymus cancer	0.0429	0.0441	CcSEcCtD
Norethindrone—Acne—Octreotide—thymus cancer	0.0364	0.0375	CcSEcCtD
Norethindrone—Neoplasm malignant—Octreotide—thymus cancer	0.0359	0.0369	CcSEcCtD
Norethindrone—Breast pain—Octreotide—thymus cancer	0.0351	0.0361	CcSEcCtD
Norethindrone—Amenorrhoea—Octreotide—thymus cancer	0.0349	0.0359	CcSEcCtD
Norethindrone—Jaundice cholestatic—Octreotide—thymus cancer	0.0349	0.0359	CcSEcCtD
Norethindrone—Thrombophlebitis—Octreotide—thymus cancer	0.0257	0.0264	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Octreotide—thymus cancer	0.023	0.0236	CcSEcCtD
Norethindrone—Pain in extremity—Octreotide—thymus cancer	0.0222	0.0229	CcSEcCtD
Norethindrone—Abdominal distension—Octreotide—thymus cancer	0.0194	0.0199	CcSEcCtD
Norethindrone—Weight increased—Octreotide—thymus cancer	0.0175	0.018	CcSEcCtD
Norethindrone—Drowsiness—Octreotide—thymus cancer	0.0171	0.0176	CcSEcCtD
Norethindrone—Depression—Octreotide—thymus cancer	0.0171	0.0176	CcSEcCtD
Norethindrone—Hepatobiliary disease—Octreotide—thymus cancer	0.0162	0.0167	CcSEcCtD
Norethindrone—Hepatitis—Octreotide—thymus cancer	0.0154	0.0158	CcSEcCtD
Norethindrone—Immune system disorder—Octreotide—thymus cancer	0.0139	0.0143	CcSEcCtD
Norethindrone—Alopecia—Octreotide—thymus cancer	0.0136	0.014	CcSEcCtD
Norethindrone—Mental disorder—Octreotide—thymus cancer	0.0135	0.0139	CcSEcCtD
Norethindrone—Flatulence—Octreotide—thymus cancer	0.0132	0.0136	CcSEcCtD
Norethindrone—Tension—Octreotide—thymus cancer	0.0131	0.0135	CcSEcCtD
Norethindrone—Nervousness—Octreotide—thymus cancer	0.013	0.0134	CcSEcCtD
Norethindrone—Convulsion—Octreotide—thymus cancer	0.0116	0.0119	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0113	0.0116	CcSEcCtD
Norethindrone—Anaphylactic shock—Octreotide—thymus cancer	0.0109	0.0112	CcSEcCtD
Norethindrone—Oedema—Octreotide—thymus cancer	0.0109	0.0112	CcSEcCtD
Norethindrone—Skin disorder—Octreotide—thymus cancer	0.0106	0.0109	CcSEcCtD
Norethindrone—Insomnia—Octreotide—thymus cancer	0.00989	0.0102	CcSEcCtD
Norethindrone—Somnolence—Octreotide—thymus cancer	0.00972	0.01	CcSEcCtD
Norethindrone—Dyspepsia—Octreotide—thymus cancer	0.00962	0.0099	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Octreotide—thymus cancer	0.00944	0.00971	CcSEcCtD
Norethindrone—Fatigue—Octreotide—thymus cancer	0.00943	0.00969	CcSEcCtD
Norethindrone—Gastrointestinal pain—Octreotide—thymus cancer	0.00894	0.00919	CcSEcCtD
Norethindrone—Urticaria—Octreotide—thymus cancer	0.00869	0.00893	CcSEcCtD
Norethindrone—Abdominal pain—Octreotide—thymus cancer	0.00864	0.00889	CcSEcCtD
Norethindrone—Hypersensitivity—Octreotide—thymus cancer	0.00806	0.00828	CcSEcCtD
Norethindrone—Asthenia—Octreotide—thymus cancer	0.00784	0.00807	CcSEcCtD
Norethindrone—Pruritus—Octreotide—thymus cancer	0.00774	0.00796	CcSEcCtD
Norethindrone—Dizziness—Octreotide—thymus cancer	0.00723	0.00744	CcSEcCtD
Norethindrone—Vomiting—Octreotide—thymus cancer	0.00695	0.00715	CcSEcCtD
Norethindrone—Rash—Octreotide—thymus cancer	0.00689	0.00709	CcSEcCtD
Norethindrone—Dermatitis—Octreotide—thymus cancer	0.00689	0.00708	CcSEcCtD
Norethindrone—Headache—Octreotide—thymus cancer	0.00685	0.00704	CcSEcCtD
Norethindrone—Nausea—Octreotide—thymus cancer	0.00649	0.00668	CcSEcCtD
Norethindrone—SHBG—neck—thymus cancer	0.00294	0.106	CbGeAlD
Norethindrone—SHBG—hematopoietic system—thymus cancer	0.00219	0.0792	CbGeAlD
Norethindrone—PGR—hematopoietic system—thymus cancer	0.00197	0.0713	CbGeAlD
Norethindrone—PGR—epithelium—thymus cancer	0.0018	0.0652	CbGeAlD
Norethindrone—SHBG—pituitary gland—thymus cancer	0.00162	0.0587	CbGeAlD
Norethindrone—PGR—pituitary gland—thymus cancer	0.00146	0.0529	CbGeAlD
Norethindrone—CYP2C19—hematopoietic system—thymus cancer	0.00145	0.0527	CbGeAlD
Norethindrone—SHBG—bone marrow—thymus cancer	0.0014	0.0508	CbGeAlD
Norethindrone—SHBG—thyroid gland—thymus cancer	0.0014	0.0506	CbGeAlD
Norethindrone—PGR—lymphoid tissue—thymus cancer	0.00139	0.0502	CbGeAlD
Norethindrone—PGR—thyroid gland—thymus cancer	0.00126	0.0456	CbGeAlD
Norethindrone—CYP3A5—hematopoietic system—thymus cancer	0.00115	0.0415	CbGeAlD
Norethindrone—PGR—lung—thymus cancer	0.00114	0.0414	CbGeAlD
Norethindrone—CYP3A4—hematopoietic system—thymus cancer	0.000859	0.0311	CbGeAlD
Norethindrone—PGR—lymph node—thymus cancer	0.000782	0.0283	CbGeAlD
Norethindrone—ALB—lymph node—thymus cancer	0.000717	0.026	CbGeAlD
Norethindrone—CYP3A5—lung—thymus cancer	0.000665	0.0241	CbGeAlD
Norethindrone—ABCB1—hematopoietic system—thymus cancer	0.000608	0.022	CbGeAlD
Norethindrone—ABCB1—epithelium—thymus cancer	0.000556	0.0201	CbGeAlD
Norethindrone—ABCB1—pituitary gland—thymus cancer	0.000451	0.0163	CbGeAlD
Norethindrone—ABCB1—lymphoid tissue—thymus cancer	0.000428	0.0155	CbGeAlD
Norethindrone—ABCB1—bone marrow—thymus cancer	0.00039	0.0141	CbGeAlD
Norethindrone—ABCB1—thyroid gland—thymus cancer	0.000389	0.0141	CbGeAlD
Norethindrone—ABCB1—lung—thymus cancer	0.000353	0.0128	CbGeAlD
Norethindrone—ABCB1—lymph node—thymus cancer	0.000242	0.00875	CbGeAlD
